Table 2.
Behaviour and clinical characteristics among MSM and TGW living with HIV according to timing of infection, Rio de Janeiro, Brazil, 2018 to 2020
| Characteristics | Recent infection | Non‐recent infection |
|---|---|---|
| Total | 73 | 223 |
| Number of male or transgender female sex partners in the last six months a | ||
| Median (IQR) | 4.0 (2.0 to 12.0) | 4.0 (1.0 to 10.5) |
| Anal sex practices in the last six months b | ||
| Receptive | 25 (39.7) | 53 (34.0) |
| Insertive | 9 (14.3) | 19 (12.2) |
| Both receptive and insertive | 29 (46.0) | 84 (53.8) |
| Condomless anal sex in the previous six months c | ||
| Yes | 66 (95.7) | 182 (94.3) |
| No | 3 (4.3) | 11 (5.7) |
| When was the last condomless anal sex d | ||
| ≤30 days | 46 (88.5) | 86 (70.5) e |
| >30 days | 6 (11.5) | 36 (29.5) e |
| Ever sex work f | ||
| Yes | 12 (22.2) | 31 (19.4) |
| No | 42 (77.8) | 129 (80.6) |
| Sex with partners living with HIV in the last six months g | ||
| Yes | 14 (20.0) | 46 (23.8) |
| No | 56 (80.0) | 147 (76.2) |
| Stimulant drug use in the last six months h , i | ||
| Yes | 12 (19.7) | 43 (22.2) |
| No | 49 (80.3) | 151 (77.8) |
| Cocaine use in the last six months h | ||
| Yes | 7 (12.5) | 37 (19.6) |
| No | 49 (87.5) | 152 (80.4) |
| VL log i | ||
| Median (IQR), log | 3.9 (3.3 to 5.0) | 4.3 (3.8 to 4.9) |
| CD4 j | ||
| Median (IQR), cells/mm3 | 564 (391 to 830) | 405 (280 to 578) e |
a
n = 228
b
n = 219
c
n = 262
d
n = 174
e
p < 0.05 for HIV‐negative or non‐recent individuals when compared with recent infection (chi‐square test or Wilcoxon test) (in bold)
f
n = 214
g
n = 263
h
n = 255
i
We defined the use of any of the following as stimulant use: cocaine (powder, crack or paste), amphetamines or club drugs (ecstasy, LSD, GHB and ketamine)
h
n = 245
i
n = 249
j
n = 208.